CIK 0001583648 · Non-accelerated filer<br>Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 300784346
- Phone
- (484) 253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-02 | KIRITSY CHRISTOPHER P Director | Sale | −313 | $157.00 | $49K | 250 |
| 2026-09-02 | KIRITSY CHRISTOPHER P Director | Option exercise · Stock Option (Right to Buy) | −313 | 0 | ||
| 2026-08-19 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
| 2026-08-19 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,302 |
| 2026-08-19 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,500 | $151.39 | $227K | 2,802 |
| 2026-08-19 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,998 | $151.80 | $303K | 804 |
| 2026-08-19 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −400 | $153.00 | $61K | 404 |
| 2026-08-19 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −102 | $155.59 | $16K | 302 |
| 2026-08-19 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −302 | $156.77 | $47K | 0 |
| 2026-08-19 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,154 | 4,319 | ||
| 2026-08-19 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 4,296 | ||
| 2026-07-15 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,154 | $7.14 | $15K | 2,154 |
| 2026-07-15 | Goin Kathleen Chief Operating Officer | Option exercise 10b5-1 | +2,148 | $9.08 | $20K | 4,302 |
| 2026-07-15 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −522 | $147.14 | $77K | 3,780 |
| 2026-07-15 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −840 | $148.40 | $125K | 2,940 |
| 2026-07-15 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,029 | $149.27 | $154K | 1,911 |
| 2026-07-15 | Goin Kathleen Chief Operating Officer | Sale 10b5-1 | −1,911 | $150.25 | $287K | 0 |
| 2026-07-15 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,154 | 6,473 | ||
| 2026-07-15 | Goin Kathleen Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,148 | 6,444 | ||
| 2026-06-29 | Pauls Matthew Director | Grant or award · Stock Option (Right to Buy) | +6,000 | 6,000 |
Page 4 of 12 · 232 trades